IRIS
RIGOTTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.474
NA - Nord America 2.396
EU - Europa 2.122
SA - Sud America 368
AF - Africa 56
AN - Antartide 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.330
RU - Federazione Russa 1.357
SG - Singapore 1.006
CN - Cina 906
BR - Brasile 315
RO - Romania 269
HK - Hong Kong 256
VN - Vietnam 153
IT - Italia 123
FR - Francia 120
DE - Germania 70
GB - Regno Unito 46
IN - India 39
CA - Canada 36
ZA - Sudafrica 26
NL - Olanda 23
MX - Messico 22
AR - Argentina 21
SE - Svezia 21
FI - Finlandia 20
PL - Polonia 20
BD - Bangladesh 19
AT - Austria 16
IQ - Iraq 14
TR - Turchia 13
ES - Italia 12
EC - Ecuador 11
DZ - Algeria 10
JP - Giappone 10
ID - Indonesia 8
LT - Lituania 7
PK - Pakistan 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
MA - Marocco 5
OM - Oman 5
TN - Tunisia 5
CO - Colombia 4
KE - Kenya 4
PH - Filippine 4
CH - Svizzera 3
CL - Cile 3
EG - Egitto 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
UA - Ucraina 3
AQ - Antartide 2
AZ - Azerbaigian 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JO - Giordania 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AO - Angola 1
AU - Australia 1
BE - Belgio 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IE - Irlanda 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MK - Macedonia 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
Totale 7.420
Salva come PNG Salva come JPEG
Città #
Dallas 1.162
Singapore 512
San Jose 388
Moscow 329
Hong Kong 255
Shanghai 217
Ashburn 213
Hefei 115
Lauterbourg 99
Beijing 78
Ho Chi Minh City 53
New York 43
Los Angeles 41
Hanoi 38
Guangzhou 35
Boardman 30
Chennai 27
Milan 25
São Paulo 24
Johannesburg 23
Brooklyn 21
Nuremberg 18
Shenzhen 18
Munich 17
Santa Clara 17
Amsterdam 16
Orem 16
Rome 16
Warsaw 16
London 14
Chicago 13
Assago 12
Helsinki 12
Montreal 12
Rio de Janeiro 12
Stockholm 11
Boston 10
Frankfurt am Main 10
Mexico City 10
Poplar 10
Tokyo 10
Toronto 10
Belo Horizonte 9
Phoenix 9
Atlanta 8
Da Nang 8
Haiphong 8
Houston 8
Jiaxing 8
Manchester 8
Paris 8
San Francisco 8
Algiers 7
Charlotte 7
Seattle 7
Washington 7
Baghdad 6
Brasília 6
Cesano Boscone 6
Denver 6
Guarulhos 6
Porto Alegre 6
Quito 6
Thái Nguyên 6
Wuxi 6
Ankara 5
Brescia 5
Campinas 5
Curitiba 5
Fuzhou 5
Lawrence 5
Princeton 5
Reston 5
Tashkent 5
Vienna 5
Buenos Aires 4
Buffalo 4
Dhaka 4
Fortaleza 4
Guayaquil 4
Lappeenranta 4
Muscat 4
Nairobi 4
Turku 4
Uberlândia 4
West Jordan 4
Bến Tre 3
Carney 3
Changsha 3
Charleston 3
Chongqing 3
Council Bluffs 3
Florianópolis 3
Foshan 3
Goiânia 3
Hải Dương 3
Kassel 3
Klosterneuburg 3
Modena 3
Mumbai 3
Totale 4.308
Salva come PNG Salva come JPEG
Nome #
105.3: Analysis of Autoimmune Re-activation After COVID-19 mRNA Vaccination in Pancreas Transplant Recipients 1.379
COVID-19 and kidney transplantation: an Italian Survey and Consensus 93
Acute rejection features in dual kidney transplant recipients fromelderly donors: comparison of calcineurin inhibitor-based and calcineurininhibitor-free immunosuppressive protocols 92
First World Consensus Conference on Pancreas Transplantation: Part II - recommendations 90
Comparison of CMV ELISPOT and CMV Quantiferon™ interferon-γ releasing assays in assessing risk of CMV infection in kidney transplant recipients 88
C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients:single-center incidence and outcome 88
ABCB1 Genotypes Predict Cyclosporine-Related Adverse Events and Kidney Allograft Outcome 87
The era of the new directly acting antivirals: Has the time come for kidney transplant only in compensated cirrhosis? 86
ADVANTAGES OF PSI plus LOW-DOSE CNI VS PSI ALONE IN DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS 83
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment 82
Kidney Donation after circulatory death: The Veneto Region experience in Italy 82
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 80
First world consensus conference on pancreas transplantation: Part I—Methods and results of literature search 80
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 79
A RARE CAUSE OF ULCERATIVE LESION OF THE PALATE AND FEVER IN A RENAL-TRANSPLANT RECIPIENT 79
Alefacept Combined With Tacrolimus, Mycophenolate Mofetil and Steroids in De Novo Kidney Transplantation: A Randomized Controlled Trial 78
Correction to: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression (Oncogenesis, (2018), 7, 6, (46), 10.1038/s41389-018-0055-5) 78
Assessment of Adherence To Medical Regimen After Solid Organ Transplantation: the Experience of Padova University Hospital 78
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 77
Kidney exchange strategies: new aspects and applications with a focus on deceased donor-initiated chains 76
A single-center experience with 200 dual kidney transplantations 76
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids? 76
[Living donor kidney transplant: the surgical procedure] 73
Coronary Microvascular Dysfunction Predicts Long-Term Outcome in Simultaneous Pancreas-Kidney Transplantation 71
Autosomal Dominant Polycystic Kidney Disease 70
Exploring definitions of graft pancreatitis following pancreas transplantation: A scoping review 69
DNA Methylation - and Telomere - Based Biological Age Estimation as Markers of Biological Aging in Donors Kidneys 68
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: A randomized phase III study 68
Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors 65
Telemedicine monitoring in the follow-up of kidney transplant recipients: consensus indications from an Italian panel of surgeons and nephrologists after the COVID-19 experience 64
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway 63
Glomerulitis and endothelial cell enlargement in C4d(+) and C4d(-) acute rejections of renal transplant patients 59
Surgical complications in simultaneous pancreas and kidney transplantation (SPK) with enteric exocrine drainage and systemic venous drainage 59
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies 59
Pulse pressure variation guided fluid therapy during kidney transplantation: a randomized controlled trial 58
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation 58
Erratum: Optimizing utilization of kidneys from deceased donors over 60 years: Five-year outcomes after implementation of a combined clinical and histological allocation algorithm (Transplant International (2013) 26 (833)) 58
Lower Urinary Tract Symptoms in Kidney Transplant Recipients and Timing of Treatment With TURP: Impact on Renal Graft Survival and Function 58
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial 57
LONG TERM RESULTS OF A LARGE EXPERIENCE OF DOUBLE KIDNEY TRANSPLANTATION (DKT) PERFORMED AT A SINGLE CENTER 57
Outcome and quality of life of patients with augmented bladder or urinary diversion after kidney transplantation 56
SEMEIOTICA CHIRURGICA 56
Perioperative strategies: Taking care of the elderly patient with severe advanced comorbidities needing acute surgery 56
Surgical overview on kidney and pancreas transplantation 56
Transplantation: can a single criterion determine the use of ECD kidneys? 55
Headache in kidney transplantation 55
Ex Vivo open reconstruction of hilar renal artery aneurysms: a silngle-center experience 54
Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantation 52
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma 52
PROLIFERATION SIGNAL INHIBITORS (PSI) CAN BE SAFELY USED AB INITIO AFTER DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS (ED) 51
Laparoscopic and robot-assisted nephrectomy 51
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study 51
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 51
Non-compliance after solid organ transplantation: the experience of Padua University Hospital 51
DUAL KIDNEY TRANSPLANTATION FROM ELDERLY DONORS: LONG TERM OUTCOME AND HISTOLOGICAL FEATURES 51
Deceased donor-initiated Chains: first report of a successful deliberate case and its ethical implications 50
The debate on preemptive transplantation: queries and limits 50
Refinement of a primate xenotransplantation model: application of a subcutaneously implanted port as a means of gastric nutrition 50
Kidney Autotransplantation for Renal Artery Aneurysm: Case Series and a Systematic Review 50
How Long Does It Take to Acquire Mastery of Performance in Laparoscopic Living Donor Nephrectomy? A Center-Based and Surgeon-Based Operative Time CUSUM Analysis 50
Persistent Secondary Hyperparathyroidism and Vertebral Fractures in Kidney Transplantation: Role of Calcium-Sensing Receptor Polymorphisms and Vitamin D Deficiency 50
Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy 49
Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial 49
Xenotransplantation of solid organs in the pig-to-primate model 48
Organ Donors with Small Renal Cancer: Report of 3 Cases 48
Glomerulitis in acute rejection of renal transplant patients 48
In vitro and in vivoimmunomodulatory effects of cobalt protoporphyrin administered in combinationwith immunosuppressive drugs 48
Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009 48
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 48
MAXIMIZING THE SUCCESS OF TRANSPLANTATION WITH KIDNEYS FROM OLDER DONORS: LONG-TERM RESULTS OF A MULTICENTER, PROSPECTIVE STUDY 48
Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open-Label Trial 47
EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION: PRELIMINARY RESULTS OF A MULTICENTER STUDY 47
Everolimus Associated With Low-Dose Calcineurin Inhibitors, an Option in Kidney Transplant Recipients of Very Old Donors 47
Evaluation of coronary microvascular function by coronary flow reserve (cfr) measurement in simultaneous pancreas and kidney transplantation (spk) allograft recipients 46
EVALUATION OF HUMAN CYTOMEGALOVIRUS (CMV) SPECIFIC T-CELL RESPONSES PREDICTS EARLY AND LATE ONSET CMV INFECTION IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS 46
Outcome of Renal Transplantation from Very Old Donors 46
Glomerular C4d Immunoreactivity in Acute Rejection Biopsies of Renal Transplant Patients 46
Everolimus with very low-exposure cyclosporine A in de Novo kidney transplantation: A multicenter, randomized, controlled trial 46
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 45
Therapeutic apheresis in kidney AB0 incompatible transplantation 45
Refinement of a primate model: Long-term enteral administration of drugs or nutritional supplementary by a subcutaneously implanted port 45
Evaluation of Endothelial Cell Enlargement in Glomerulitis 45
Transplantation: Optimizing outcomes in elderly kidney transplant recipients 44
Sirolimus-Based Therapy For Kidney Transplantation From Expanded Criteria Donors 44
Physical Activity in Solid Organ Transplant Recipients: Organizational Aspects and Preliminary Results of the Italian Project 44
CYCLOSPORIN A AND TACROLIMUS, COMBINED WITH MYCOPHENOLIC ACID, ARE EQUALLY EFFECTIVE IN PREVENTING THE ONSET OF DE NOVO ANTI-HLA ANTIBODIES 44
Dual kidney transplantation after liver transplantation: a good option to rescue a patient from dialysis 43
Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study 43
Effects of immune suppression for transplantation on inflammatory colorectal cancer progression 43
MicroRNAs: nuovi biomarcatori predittivi di sviluppo di insufficienza renale cronica e ipertensione arteriosa nei pazienti sottoposti a nefrectomia radicale per carcinoma renale. 43
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection 42
Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials 42
Risk of renal cell cancer in people immunodepressed after solid organ transplant: Results from an Italian multicenter cohort study 42
INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS 41
Sotrastaurin, a Novel Small Molecule Inhibiting Protein Kinase C: First Clinical Results in Renal-Transplant Recipients 41
Excellent Performance of Kidneys from Octogenarian Donors Transplanted as Dual Kidney Transplantation 41
Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-Year observational results 41
EVALUATION OF CORONARY MICROVASCULAR FUNCTION BY CORONARY FLOW RESERVE (CFR) MEASUREMENT IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION (SPK) ALLOGRAFT RECIPIENTS 41
Early activation of fibrogenesis in transplanted kidneys: A study on serial renal biopsies 41
Nonadherent Behaviors After Solid Organ Transplantation 40
Totale 7.084
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 1 0 1 1 0 0 0 0 1 0 0 0
2022/202328 13 4 2 0 0 3 0 0 2 1 1 2
2023/2024329 1 1 0 0 0 0 0 145 34 8 33 107
2024/20251.990 187 18 21 98 214 151 542 150 234 103 120 152
2025/20265.244 383 549 957 536 303 110 630 272 1.218 212 74 0
Totale 7.598